Search

Displaying results 6181 - 6190 of 10000 in total
  1. Drug

    Ambrosia psilostachya pollen

    go.drugbank.com/drugs/DB10387
    Approved

    Ambrosia psilostachya pollen is the pollen of the Ambrosia psilostachya plant. Ambrosia psilostachya pollen is mainly used in allergenic testing.

    Categories: Non-Standardized Pollen Allergenic Extract
  2. Drug

    Hymenoclea salsola pollen

    go.drugbank.com/drugs/DB10758
    Approved

    Hymenoclea salsola pollen is the pollen of the Hymenoclea salsola plant. Hymenoclea salsola pollen is mainly used in allergenic testing.

    Categories: Non-Standardized Pollen Allergenic Extract
  3. Drug

    Ambrosia dumosa pollen

    go.drugbank.com/drugs/DB10871
    Approved

    Ambrosia dumosa pollen is the pollen of the Ambrosia dumosa plant. Ambrosia dumosa pollen is mainly used in allergenic testing.

    Categories: Non-Standardized Pollen Allergenic Extract
  4. Drug

    Deuremidevir

    go.drugbank.com/drugs/DB26606
    Investigational

    Deuremidevir is under investigation in clinical trial NCT06328400 (A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Oral Deuremidevir Hydrobromide for Suspension). … Deuremidevir is a small molecule drug.

  5. Drug

    Iratumumab

    go.drugbank.com/drugs/DB05550
    Investigational

    Molecular weight is approximately 170,000 daltons. In phase I/II clinical trials for treatment of CD30+ lymphomas.

  6. Drug

    CGC-11047

    go.drugbank.com/drugs/DB05722
    Investigational

    CGC-11047 is a polyamine analog designed to halt cell growth and induce apoptosis.

  7. Drug

    AdimrSC-2f

    go.drugbank.com/drugs/DB16436
    Investigational

    The AdimrSC-2f (SARS-CoV-2) vaccine is developed through Adimmune Corporation, the only influenza vaccine manufacturer with both EU GMP and US FDA certification in Asia[L30553]. … A phase I study (NCT04522089) will investigate the safety and immunogenicity of the vaccine[L30553, L30548].

  8. Drug

    Felis catus skin

    go.drugbank.com/drugs/DB10399
    Approved

    Felis catus skin or pelt is used in allergenic testing.

  9. Drug

    EpiVacCorona

    go.drugbank.com/drugs/DB16439
    Investigational

    It is currently being tested in Phase I/II clinical trials for safety and immunogenicity (NCT04527575)[L30608, L30613]. … EpiVacCorona Vaccine, developed by the Vektor State Research Center of Virology and Biotechnology in Russia, is based on peptide-antigens that facilitate immunity to the SARS-CoV-2 virus[L30608].

  10. Drug

    Esuberaprost

    go.drugbank.com/drugs/DB18464
    Investigational

    Esuberaprost (GP-1681), a drug intended for participants with pulmonary arterial hypertension, was under investigation in clinical trial NCT03657095 to evaluate its efficacy and safety.

    Synonyms: (+)-4-((1r,2r,3as,8bs)-2-hydroxy-1-((1e,3s,4s)-3-hydroxy-4-methyl-oct-1-en-6-yn-1-yl)-2,3,3a,8b-tetrahydro-1h-cyclopenta(b)(1)benzofuran-5-yl)butanoic acid